JP Morgan Healthcare Conference, Day Three: NanoString, BD, Bio-Rad, Cepheid, Quidel, GenMark, PacBio, Adaptive Biotechnologies | GenomeWeb

SAN FRANCISCO (GenomeWeb News) – The 32nd Annual JP Morgan Healthcare Conference continued here Wednesday with presentations from several life science tools and diagnostic firms.

The following are capsules from the presentations and breakout sessions of Nanostring, Becton Dickinson, Bio-Rad, Cepheid, Quidel, GenMark, Pacific Biosciences, and Adaptive Biotechnologies. Coverage of Danaher's presentation, in which the company discussed its acquisition plans, is available here.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.

Some science companies will be taking part in next month's March for Science, Fortune reports.

In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.

Shale oil companies are turning to DNA sequencing to find spots to drill, Reuters reports.